Login to Your Account



Other News To Note


Tuesday, February 8, 2011
Inovio Pharmaceuticals Inc., of Blue Bell, Pa., announced that its DNA vaccine delivery technology, which provides the enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in Human Vaccines.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription